Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$42.38 +0.20 (+0.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Income from Discontinued Operations (2011)

Updated

Supernus Pharmaceuticals (SUPN) recorded Income from Discontinued Operations of $76.39 million in Q4 2011.

Analysis

Supernus Pharmaceuticals (SUPN) Income from Discontinued Operations (2011) Analysis & Trends

For FY2011, Supernus Pharmaceuticals reported Income from Discontinued Operations of $77.04 million.

  • Across earlier years, Income from Discontinued Operations came in at $612,000 in FY2010.
  • Per Business Quant, the preceding three quarters came in at $417,000 (Q3 2011), $1.56 million (Q2 2011) and -$1.33 million (Q1 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Supernus Pharmaceuticals 2.47 Bn 1.12 Bn 185.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 76.39 Mn
Sep 30, 2011 417,000.00
Jun 30, 2011 1.56 Mn
Mar 31, 2011 -1.33 Mn
API Access

Supernus Pharmaceuticals Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=SUPN&period=max&api_key=YOUR_API_KEY